Morgan Stanley
CRDF icon

Morgan Stanley’s Cardiff Oncology CRDF Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.51M Buy
795,746
+97,218
+14% +$306K ﹤0.01% 4563
2025
Q1
$2.19M Buy
698,528
+156,139
+29% +$490K ﹤0.01% 4544
2024
Q4
$2.35M Buy
542,389
+44,247
+9% +$192K ﹤0.01% 4593
2024
Q3
$1.33M Sell
498,142
-15,082
-3% -$40.3K ﹤0.01% 4880
2024
Q2
$1.14M Buy
513,224
+433,799
+546% +$963K ﹤0.01% 4881
2024
Q1
$424K Buy
79,425
+48,945
+161% +$261K ﹤0.01% 5388
2023
Q4
$45.1K Buy
30,480
+11,480
+60% +$17K ﹤0.01% 6418
2023
Q3
$26.4K Buy
19,000
+3,287
+21% +$4.57K ﹤0.01% 6402
2023
Q2
$23.1K Sell
15,713
-188,135
-92% -$277K ﹤0.01% 6526
2023
Q1
$336K Sell
203,848
-76,918
-27% -$127K ﹤0.01% 5467
2022
Q4
$393K Sell
280,766
-95,970
-25% -$134K ﹤0.01% 5360
2022
Q3
$580K Buy
376,736
+13,017
+4% +$20K ﹤0.01% 5194
2022
Q2
$800K Buy
363,719
+152,265
+72% +$335K ﹤0.01% 5158
2022
Q1
$524K Sell
211,454
-339,520
-62% -$841K ﹤0.01% 5380
2021
Q4
$3.31M Buy
550,974
+442,874
+410% +$2.66M ﹤0.01% 4159
2021
Q3
$719K Sell
108,100
-359,361
-77% -$2.39M ﹤0.01% 5281
2021
Q2
$3.11M Buy
467,461
+442,072
+1,741% +$2.94M ﹤0.01% 4253
2021
Q1
$235K Buy
25,389
+8,018
+46% +$74.2K ﹤0.01% 5564
2020
Q4
$313K Buy
17,371
+5,751
+49% +$104K ﹤0.01% 5348
2020
Q3
$165K Sell
11,620
-12,719
-52% -$181K ﹤0.01% 5206
2020
Q2
$122K Buy
24,339
+11,023
+83% +$55.3K ﹤0.01% 5307
2020
Q1
$13K Sell
13,316
-1,572
-11% -$1.54K ﹤0.01% 5949
2019
Q4
$18K Sell
14,888
-10,134
-41% -$12.3K ﹤0.01% 6119
2019
Q3
$38K Sell
25,022
-2,057
-8% -$3.12K ﹤0.01% 5821
2019
Q2
$68K Buy
27,079
+26,976
+26,190% +$67.7K ﹤0.01% 5488
2019
Q1
$0 Sell
103
-477
-82% ﹤0.01% 6606
2018
Q4
$0 Buy
580
+202
+53% ﹤0.01% 6609
2018
Q3
$0 Buy
378
+44
+13% ﹤0.01% 6721
2018
Q2
$0 Sell
334
-3,886
-92% ﹤0.01% 6674
2018
Q1
$1K Sell
4,220
-1,799
-30% -$426 ﹤0.01% 6530
2017
Q4
$2K Sell
6,019
-4,433
-42% -$1.47K ﹤0.01% 6439
2017
Q3
$8K Sell
10,452
-63,658
-86% -$48.7K ﹤0.01% 6209
2017
Q2
$93K Sell
74,110
-2,262
-3% -$2.84K ﹤0.01% 5663
2017
Q1
$89K Sell
76,372
-89,462
-54% -$104K ﹤0.01% 5641
2016
Q4
$347K Buy
165,834
+75,582
+84% +$158K ﹤0.01% 5114
2016
Q3
$405K Sell
90,252
-346,217
-79% -$1.55M ﹤0.01% 4639
2016
Q2
$1.98M Buy
436,469
+328,978
+306% +$1.49M ﹤0.01% 3430
2016
Q1
$500K Sell
107,491
-24,834
-19% -$116K ﹤0.01% 4444
2015
Q4
$714K Buy
132,325
+18,012
+16% +$97.2K ﹤0.01% 4292
2015
Q3
$650K Sell
114,313
-8,520
-7% -$48.4K ﹤0.01% 4440
2015
Q2
$1.25M Buy
122,833
+82,461
+204% +$837K ﹤0.01% 4033
2015
Q1
$275K Buy
40,372
+28,382
+237% +$193K ﹤0.01% 5031
2014
Q4
$52K Sell
11,990
-45,721
-79% -$198K ﹤0.01% 5805
2014
Q3
$264K Sell
57,711
-294,608
-84% -$1.35M ﹤0.01% 4987
2014
Q2
$1.23M Buy
352,319
+86,504
+33% +$303K ﹤0.01% 3886
2014
Q1
$1.52M Sell
265,815
-16,809
-6% -$96.3K ﹤0.01% 3661
2013
Q4
$1.62M Sell
282,624
-7,218
-2% -$41.4K ﹤0.01% 3538
2013
Q3
$2.08M Buy
+289,842
New +$2.08M ﹤0.01% 3179